| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 DNAJA3 ARHGAP32 RANGAP1 RGPD8 RGPD3 RALGPS2 RGPD1 RAPGEF1 RIC1 RGPD5 | 2.36e-07 | 507 | 59 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 DNAJA3 ARHGAP32 RANGAP1 RGPD8 RGPD3 RALGPS2 RGPD1 RAPGEF1 RIC1 RGPD5 | 2.36e-07 | 507 | 59 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | SUMO ligase activity | 3.21e-07 | 20 | 59 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 3.77e-06 | 36 | 59 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.43e-05 | 50 | 59 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.77e-05 | 279 | 59 | 7 | GO:0005096 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.81e-05 | 53 | 59 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 7.62e-05 | 28 | 59 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD4 DNAJA3 ARHGAP32 RANGAP1 ABCA2 RGPD8 RGPD3 RALGPS2 RGPD1 RAPGEF1 ADGRV1 RIC1 RGPD5 | 2.06e-04 | 1418 | 59 | 13 | GO:0030234 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 2.22e-04 | 293 | 59 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | gap junction channel activity involved in cell communication by electrical coupling | 3.05e-04 | 9 | 59 | 2 | GO:1903763 | |
| GeneOntologyMolecularFunction | transporter activity | GJB2 SLC25A21 ABCA2 ATP8B4 P2RX1 SLC16A1 ATP8A2 GJB6 SLC4A10 SLC35B2 SLC25A25 SLC2A2 | 3.28e-04 | 1289 | 59 | 12 | GO:0005215 |
| GeneOntologyMolecularFunction | small GTPase binding | 3.63e-04 | 321 | 59 | 6 | GO:0031267 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 4.25e-04 | 614 | 59 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 4.61e-04 | 51 | 59 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 4.64e-04 | 11 | 59 | 2 | GO:0043139 | |
| GeneOntologyMolecularFunction | GTPase binding | 6.64e-04 | 360 | 59 | 6 | GO:0051020 | |
| GeneOntologyMolecularFunction | antiporter activity | 7.40e-04 | 138 | 59 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | floppase activity | 1.00e-03 | 16 | 59 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.54e-03 | 749 | 59 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.80e-03 | 296 | 59 | 5 | GO:0015291 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 2.09e-03 | 23 | 59 | 2 | GO:0005346 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GJB2 SLC25A21 ABCA2 P2RX1 SLC16A1 GJB6 SLC4A10 SLC35B2 SLC25A25 SLC2A2 | 2.22e-03 | 1180 | 59 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | gap junction channel activity | 2.46e-03 | 25 | 59 | 2 | GO:0005243 | |
| GeneOntologyMolecularFunction | isomerase activity | 2.50e-03 | 192 | 59 | 4 | GO:0016853 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 2.67e-03 | 26 | 59 | 2 | GO:0000295 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 2.78e-03 | 477 | 59 | 6 | GO:0022804 | |
| GeneOntologyMolecularFunction | acyl-CoA hydrolase activity | 3.09e-03 | 28 | 59 | 2 | GO:0016289 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 3.10e-03 | 656 | 59 | 7 | GO:0008047 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 3.31e-03 | 29 | 59 | 2 | GO:0015216 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 3.78e-03 | 31 | 59 | 2 | GO:0005310 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 4.02e-03 | 32 | 59 | 2 | GO:0005452 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 4.27e-03 | 33 | 59 | 2 | GO:0015215 | |
| GeneOntologyMolecularFunction | wide pore channel activity | 5.35e-03 | 37 | 59 | 2 | GO:0022829 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 5.93e-03 | 39 | 59 | 2 | GO:0015605 | |
| GeneOntologyMolecularFunction | 4 iron, 4 sulfur cluster binding | 8.52e-03 | 47 | 59 | 2 | GO:0051539 | |
| GeneOntologyMolecularFunction | thiolester hydrolase activity | 8.52e-03 | 47 | 59 | 2 | GO:0016790 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 2.42e-09 | 20 | 59 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 7.53e-09 | 9 | 59 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.25e-08 | 10 | 59 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 4.23e-08 | 13 | 59 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 5.92e-08 | 14 | 59 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 4.14e-06 | 38 | 59 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 6.86e-06 | 249 | 59 | 7 | GO:0015931 | |
| GeneOntologyBiologicalProcess | nuclear export | 1.46e-05 | 185 | 59 | 6 | GO:0051168 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 1.72e-05 | 54 | 59 | 4 | GO:0018208 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 5.08e-05 | 71 | 59 | 4 | GO:0006111 | |
| GeneOntologyBiologicalProcess | mRNA transport | 5.91e-05 | 145 | 59 | 5 | GO:0051028 | |
| GeneOntologyBiologicalProcess | protein folding | 7.19e-05 | 246 | 59 | 6 | GO:0006457 | |
| GeneOntologyBiologicalProcess | nuclear transport | 9.87e-05 | 378 | 59 | 7 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 9.87e-05 | 378 | 59 | 7 | GO:0006913 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.43e-04 | 175 | 59 | 5 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.43e-04 | 175 | 59 | 5 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.55e-04 | 178 | 59 | 5 | GO:0051236 | |
| GeneOntologyBiologicalProcess | gap junction-mediated intercellular transport | 1.67e-04 | 7 | 59 | 2 | GO:1990349 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 2.37e-04 | 195 | 59 | 5 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 2.73e-04 | 201 | 59 | 5 | GO:0051170 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 2.88e-04 | 111 | 59 | 4 | GO:0006094 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 3.29e-04 | 115 | 59 | 4 | GO:0019319 | |
| GeneOntologyBiologicalProcess | RNA localization | 3.88e-04 | 217 | 59 | 5 | GO:0006403 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 4.00e-04 | 121 | 59 | 4 | GO:0046364 | |
| GeneOntologyBiologicalProcess | intercellular transport | 4.35e-04 | 11 | 59 | 2 | GO:0010496 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 5.55e-04 | 132 | 59 | 4 | GO:0043255 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 5.77e-04 | 362 | 59 | 6 | GO:0034504 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 5.88e-04 | 134 | 59 | 4 | GO:0010906 | |
| GeneOntologyBiologicalProcess | organic anion transport | 6.45e-04 | 515 | 59 | 7 | GO:0015711 | |
| GeneOntologyBiologicalProcess | lipid translocation | 6.78e-04 | 60 | 59 | 3 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 8.56e-04 | 65 | 59 | 3 | GO:0097035 | |
| GeneOntologyBiologicalProcess | sister chromatid cohesion | 9.35e-04 | 67 | 59 | 3 | GO:0007062 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 8.38e-12 | 8 | 59 | 5 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.75e-11 | 10 | 59 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 2.96e-09 | 21 | 59 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | annulate lamellae | 5.61e-08 | 14 | 59 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.70e-07 | 18 | 59 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.68e-07 | 20 | 59 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | nuclear pore | 4.01e-07 | 101 | 59 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | inclusion body | 5.51e-06 | 90 | 59 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RGPD4 RANGAP1 GJB2 FAT1 RGPD8 RGPD3 RGPD1 RAPGEF1 PAM ADGRV1 | 2.59e-04 | 934 | 59 | 10 | GO:0048471 |
| GeneOntologyCellularComponent | nuclear membrane | 4.44e-04 | 349 | 59 | 6 | GO:0031965 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 6.97e-04 | 14 | 59 | 2 | GO:1990531 | |
| GeneOntologyCellularComponent | nuclear envelope | 9.74e-04 | 560 | 59 | 7 | GO:0005635 | |
| GeneOntologyCellularComponent | connexin complex | 1.74e-03 | 22 | 59 | 2 | GO:0005922 | |
| HumanPheno | Lip fissure | 3.95e-05 | 3 | 19 | 2 | HP:0031250 | |
| HumanPheno | Cobblestone-like hyperkeratosis | 7.87e-05 | 4 | 19 | 2 | HP:0031288 | |
| HumanPheno | Dilatated internal auditory canal | 1.31e-04 | 5 | 19 | 2 | HP:0004458 | |
| HumanPheno | Hair follicle neoplasm | 1.31e-04 | 5 | 19 | 2 | HP:0012843 | |
| HumanPheno | Trichilemmoma | 1.31e-04 | 5 | 19 | 2 | HP:0012844 | |
| MousePheno | aneuploidy | 4.49e-11 | 61 | 51 | 8 | MP:0004024 | |
| MousePheno | abnormal chromosome number | 7.56e-10 | 86 | 51 | 8 | MP:0004023 | |
| MousePheno | abnormal chromosome morphology | 1.60e-08 | 126 | 51 | 8 | MP:0003702 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 2.77e-07 | 16 | 51 | 4 | MP:0003701 | |
| MousePheno | abnormal cell nucleus morphology | 3.04e-07 | 184 | 51 | 8 | MP:0003111 | |
| MousePheno | abnormal morula morphology | 2.21e-06 | 26 | 51 | 4 | MP:0012058 | |
| MousePheno | increased liver tumor incidence | 2.95e-06 | 111 | 51 | 6 | MP:0008019 | |
| MousePheno | increased hepatobiliary system tumor incidence | 2.95e-06 | 111 | 51 | 6 | MP:0010297 | |
| MousePheno | decreased tumor latency | 4.02e-06 | 30 | 51 | 4 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 4.60e-06 | 31 | 51 | 4 | MP:0012129 | |
| MousePheno | increased hepatocellular carcinoma incidence | 5.35e-06 | 70 | 51 | 5 | MP:0003331 | |
| MousePheno | abnormal tumor latency | 6.72e-06 | 34 | 51 | 4 | MP:0010307 | |
| MousePheno | abnormal mitosis | 6.73e-06 | 128 | 51 | 6 | MP:0004046 | |
| MousePheno | increased lung carcinoma incidence | 9.13e-06 | 78 | 51 | 5 | MP:0008714 | |
| MousePheno | abnormal blastocyst formation | 1.18e-05 | 39 | 51 | 4 | MP:0012128 | |
| MousePheno | abnormal eye electrophysiology | 1.76e-05 | 228 | 51 | 7 | MP:0005551 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 2.41e-05 | 160 | 51 | 6 | MP:0005659 | |
| MousePheno | abnormal preimplantation embryo development | 3.50e-05 | 171 | 51 | 6 | MP:0009781 | |
| MousePheno | increased lung tumor incidence | 4.25e-05 | 107 | 51 | 5 | MP:0008014 | |
| MousePheno | increased respiratory system tumor incidence | 4.25e-05 | 107 | 51 | 5 | MP:0010298 | |
| MousePheno | decreased susceptibility to weight gain | 5.61e-05 | 186 | 51 | 6 | MP:0010182 | |
| MousePheno | abnormal rod electrophysiology | 7.06e-05 | 119 | 51 | 5 | MP:0004021 | |
| MousePheno | increased energy expenditure | 7.50e-05 | 196 | 51 | 6 | MP:0004889 | |
| MousePheno | increased carcinoma incidence | 7.71e-05 | 197 | 51 | 6 | MP:0002038 | |
| MousePheno | increased lipogenesis | 7.79e-05 | 4 | 51 | 2 | MP:0020867 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 9.10e-05 | 203 | 51 | 6 | MP:0011094 | |
| MousePheno | abnormal cell cycle | 9.60e-05 | 520 | 51 | 9 | MP:0003077 | |
| MousePheno | increased incidence of tumors by chemical induction | 1.57e-04 | 141 | 51 | 5 | MP:0004499 | |
| MousePheno | increased malignant tumor incidence | 2.12e-04 | 237 | 51 | 6 | MP:0002018 | |
| MousePheno | embryonic lethality before implantation | 2.37e-04 | 242 | 51 | 6 | MP:0006204 | |
| MousePheno | increased incidence of induced tumors | 4.06e-04 | 173 | 51 | 5 | MP:0002021 | |
| MousePheno | enlarged epididymis | 4.58e-04 | 99 | 51 | 4 | MP:0004931 | |
| MousePheno | increased sarcoma incidence | 5.13e-04 | 102 | 51 | 4 | MP:0002032 | |
| MousePheno | abnormal preimplantation embryo morphology | 5.47e-04 | 283 | 51 | 6 | MP:0014137 | |
| MousePheno | abnormal lipogenesis | 5.76e-04 | 10 | 51 | 2 | MP:0020866 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 6.15e-04 | 107 | 51 | 4 | MP:0003694 | |
| MousePheno | abnormal intracellular organelle morphology | 7.44e-04 | 546 | 51 | 8 | MP:0014239 | |
| MousePheno | abnormal blastocyst hatching | 7.55e-04 | 113 | 51 | 4 | MP:0003693 | |
| MousePheno | optic nerve degeneration | 8.41e-04 | 12 | 51 | 2 | MP:0006219 | |
| MousePheno | abnormal susceptibility to weight gain | 8.67e-04 | 309 | 51 | 6 | MP:0011117 | |
| MousePheno | abnormal energy expenditure | 9.27e-04 | 313 | 51 | 6 | MP:0005450 | |
| MousePheno | abnormal embryo development | RGPD4 AMD1 RANGAP1 GJB2 DCAF13 DDX12P RGPD8 RGPD3 RGPD1 BCOR CARS2 HORMAD1 LFNG | 9.93e-04 | 1370 | 51 | 13 | MP:0001672 |
| MousePheno | abnormal energy homeostasis | 1.07e-03 | 322 | 51 | 6 | MP:0005448 | |
| MousePheno | abnormal startle reflex | 1.24e-03 | 591 | 51 | 8 | MP:0001486 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | 1.71e-03 | 772 | 51 | 9 | MP:0014259 | |
| Domain | Grip | 1.10e-10 | 11 | 58 | 5 | SM00755 | |
| Domain | GRIP | 1.10e-10 | 11 | 58 | 5 | PF01465 | |
| Domain | Ran_BP1 | 1.89e-10 | 12 | 58 | 5 | PF00638 | |
| Domain | GRIP_dom | 1.89e-10 | 12 | 58 | 5 | IPR000237 | |
| Domain | GRIP | 1.89e-10 | 12 | 58 | 5 | PS50913 | |
| Domain | RANBD1 | 1.89e-10 | 12 | 58 | 5 | PS50196 | |
| Domain | RanBD | 3.06e-10 | 13 | 58 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 3.06e-10 | 13 | 58 | 5 | IPR000156 | |
| Domain | GCC2_Rab_bind | 2.91e-09 | 7 | 58 | 4 | IPR032023 | |
| Domain | Rab_bind | 2.91e-09 | 7 | 58 | 4 | PF16704 | |
| Domain | - | 1.73e-08 | 10 | 58 | 4 | 1.10.220.60 | |
| Domain | TPR-contain_dom | 6.96e-06 | 150 | 58 | 6 | IPR013026 | |
| Domain | TPR-like_helical_dom | 7.52e-06 | 233 | 58 | 7 | IPR011990 | |
| Domain | TPR_REGION | 1.20e-05 | 165 | 58 | 6 | PS50293 | |
| Domain | TPR | 1.20e-05 | 165 | 58 | 6 | PS50005 | |
| Domain | - | 4.32e-05 | 207 | 58 | 6 | 1.25.40.10 | |
| Domain | TPR | 4.97e-05 | 129 | 58 | 5 | SM00028 | |
| Domain | TPR_repeat | 5.75e-05 | 133 | 58 | 5 | IPR019734 | |
| Domain | TPR_1 | 1.75e-04 | 90 | 58 | 4 | PF00515 | |
| Domain | TPR_1 | 1.75e-04 | 90 | 58 | 4 | IPR001440 | |
| Domain | PH_dom-like | 3.37e-04 | 426 | 58 | 7 | IPR011993 | |
| Domain | P_typ_ATPase_c | 8.42e-04 | 14 | 58 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 8.42e-04 | 14 | 58 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 8.42e-04 | 14 | 58 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 8.42e-04 | 14 | 58 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 8.42e-04 | 14 | 58 | 2 | PF16209 | |
| Domain | - | 1.31e-03 | 391 | 58 | 6 | 2.30.29.30 | |
| Domain | CONNEXINS_1 | 1.57e-03 | 19 | 58 | 2 | PS00407 | |
| Domain | CONNEXINS_2 | 1.74e-03 | 20 | 58 | 2 | PS00408 | |
| Domain | Connexin | 1.74e-03 | 20 | 58 | 2 | IPR000500 | |
| Domain | Connexin_CCC | 1.74e-03 | 20 | 58 | 2 | IPR019570 | |
| Domain | Connexin_N | 1.74e-03 | 20 | 58 | 2 | IPR013092 | |
| Domain | Connexin | 1.74e-03 | 20 | 58 | 2 | PF00029 | |
| Domain | Connexin_CCC | 1.74e-03 | 20 | 58 | 2 | SM01089 | |
| Domain | Connexin_CS | 1.74e-03 | 20 | 58 | 2 | IPR017990 | |
| Domain | CNX | 1.74e-03 | 20 | 58 | 2 | SM00037 | |
| Domain | RASGEF | 2.94e-03 | 26 | 58 | 2 | PS00720 | |
| Domain | - | 3.21e-03 | 95 | 58 | 3 | 2.60.120.200 | |
| Domain | RASGEF_CAT | 3.65e-03 | 29 | 58 | 2 | PS50009 | |
| Domain | RasGEF | 3.90e-03 | 30 | 58 | 2 | PF00617 | |
| Domain | - | 3.90e-03 | 30 | 58 | 2 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 3.90e-03 | 30 | 58 | 2 | IPR023578 | |
| Domain | RASGEF_cat_dom | 3.90e-03 | 30 | 58 | 2 | IPR001895 | |
| Domain | RasGEF | 3.90e-03 | 30 | 58 | 2 | SM00147 | |
| Domain | - | 4.43e-03 | 32 | 58 | 2 | 3.40.1110.10 | |
| Domain | Mit_carrier | 4.43e-03 | 32 | 58 | 2 | IPR002067 | |
| Domain | - | 4.43e-03 | 32 | 58 | 2 | 2.70.150.10 | |
| Domain | ConA-like_dom | 4.76e-03 | 219 | 58 | 4 | IPR013320 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.74e-09 | 18 | 47 | 5 | MM1549 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 6.93e-07 | 51 | 47 | 5 | MM15151 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 4.13e-06 | 129 | 47 | 6 | MM14894 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 4.20e-06 | 73 | 47 | 5 | MM14948 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 9.08e-06 | 40 | 47 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.00e-05 | 41 | 47 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.11e-05 | 42 | 47 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.22e-05 | 43 | 47 | 4 | MM14609 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.31e-05 | 92 | 47 | 5 | MM14951 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.74e-05 | 47 | 47 | 4 | MM14939 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.97e-05 | 100 | 47 | 5 | MM14561 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.06e-05 | 49 | 47 | 4 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.23e-05 | 50 | 47 | 4 | MM14610 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.27e-05 | 55 | 47 | 4 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 4.03e-05 | 58 | 47 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 4.03e-05 | 58 | 47 | 4 | MM14736 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 4.10e-05 | 193 | 47 | 6 | MM14890 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 4.20e-05 | 117 | 47 | 5 | MM15387 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 5.29e-05 | 202 | 47 | 6 | MM15362 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 6.33e-05 | 65 | 47 | 4 | MM15147 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.02e-04 | 141 | 47 | 5 | MM15266 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 1.19e-04 | 234 | 47 | 6 | MM14898 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.57e-04 | 82 | 47 | 4 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.72e-04 | 84 | 47 | 4 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.89e-04 | 86 | 47 | 4 | MM15413 | |
| Pathway | REACTOME_SUMOYLATION | 2.38e-04 | 169 | 47 | 5 | MM14919 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 2.65e-04 | 271 | 47 | 6 | MM15388 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 5.53e-04 | 114 | 47 | 4 | MM15361 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.59e-03 | 257 | 47 | 5 | MM14755 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.68e-03 | 681 | 47 | 8 | MM14985 | |
| Pathway | REACTOME_M_PHASE | 1.71e-03 | 387 | 47 | 6 | MM15364 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.01e-03 | 271 | 47 | 5 | MM15406 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.73e-03 | 736 | 47 | 8 | M27287 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 2.70e-13 | 7 | 60 | 5 | 15710750 | |
| Pubmed | 3.23e-12 | 10 | 60 | 5 | 27160050 | ||
| Pubmed | 5.91e-12 | 11 | 60 | 5 | 34110283 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 21205196 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 18949001 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 25187515 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 9037092 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 8603673 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 26632511 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 24403063 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 2.79e-10 | 7 | 60 | 4 | 11353387 | |
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 30944974 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 38838144 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 2.79e-10 | 7 | 60 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 2.79e-10 | 7 | 60 | 4 | 17372272 | |
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 38657106 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 12191015 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 22821000 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 20682751 | ||
| Pubmed | 3.32e-10 | 22 | 60 | 5 | 27717094 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 5.57e-10 | 8 | 60 | 4 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 5.57e-10 | 8 | 60 | 4 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 5.57e-10 | 8 | 60 | 4 | 28745977 | |
| Pubmed | 5.57e-10 | 8 | 60 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 5.57e-10 | 8 | 60 | 4 | 21310149 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.00e-09 | 9 | 60 | 4 | 18394993 | |
| Pubmed | 1.00e-09 | 9 | 60 | 4 | 11553612 | ||
| Pubmed | 1.00e-09 | 9 | 60 | 4 | 10601307 | ||
| Pubmed | 1.00e-09 | 9 | 60 | 4 | 9733766 | ||
| Pubmed | 1.00e-09 | 9 | 60 | 4 | 28100513 | ||
| Pubmed | 1.00e-09 | 9 | 60 | 4 | 28877029 | ||
| Pubmed | 1.00e-09 | 9 | 60 | 4 | 17887960 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.67e-09 | 10 | 60 | 4 | 8857542 | |
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.67e-09 | 10 | 60 | 4 | 16332688 | |
| Pubmed | 1.67e-09 | 10 | 60 | 4 | 21859863 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 2.62e-09 | 11 | 60 | 4 | 35771867 | |
| Pubmed | 2.62e-09 | 11 | 60 | 4 | 17069463 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 5.65e-09 | 13 | 60 | 4 | 31427429 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 6.37e-09 | 146 | 60 | 7 | 23892456 | |
| Pubmed | 1.08e-08 | 15 | 60 | 4 | 14697343 | ||
| Pubmed | Early Hearing Loss upon Disruption of Slc4a10 in C57BL/6 Mice. | 9.73e-08 | 6 | 60 | 3 | 31001720 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 5.65e-07 | 38 | 60 | 4 | 12791264 | |
| Pubmed | Strain background effects and genetic modifiers of hearing in mice. | 7.97e-07 | 11 | 60 | 3 | 16579977 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 DNAJA3 RANGAP1 SLC25A21 DDX12P RGPD8 SLC16A1 HSPH1 RGPD3 RGPD1 DNA2 RGPD5 | 1.33e-06 | 1257 | 60 | 12 | 37317656 |
| Pubmed | 1.97e-06 | 215 | 60 | 6 | 35973513 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 31162818 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 28012540 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 19723508 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 23503914 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 23700267 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 25715449 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 20236118 | ||
| Pubmed | Connexin 26 variants and auditory neuropathy/dys-synchrony among children in schools for the deaf. | 2.93e-06 | 2 | 60 | 2 | 16222667 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 26490746 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 20022641 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 19887791 | ||
| Pubmed | Hearing impairment in Dutch patients with connexin 26 (GJB2) and connexin 30 (GJB6) mutations. | 2.93e-06 | 2 | 60 | 2 | 15656949 | |
| Pubmed | The association between GJB2 mutation and GJB6 gene in non syndromic hearing loss school children. | 2.93e-06 | 2 | 60 | 2 | 22106692 | |
| Pubmed | GJB2 and GJB6 Genetic Variant Curation in an Argentinean Non-Syndromic Hearing-Impaired Cohort. | 2.93e-06 | 2 | 60 | 2 | 33096615 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 20442751 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 19844737 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 17368814 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 26265468 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 25288386 | ||
| Pubmed | GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HuGE review. | 2.93e-06 | 2 | 60 | 2 | 12172392 | |
| Pubmed | Prevalence of DFNB1 mutations in Slovak patients with non-syndromic hearing loss. | 2.93e-06 | 2 | 60 | 2 | 22281373 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 24774219 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 20381175 | ||
| Pubmed | Infant hearing loss and connexin testing in a diverse population. | 2.93e-06 | 2 | 60 | 2 | 18580690 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 31200317 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 14759569 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 20563649 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 15638823 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 17695503 | ||
| Pubmed | Phenotype/genotype correlations in a DFNB1 cohort with ethnical diversity. | 2.93e-06 | 2 | 60 | 2 | 18758381 | |
| Pubmed | Performance of speech perception after cochlear implantation in DFNB1 patients. | 2.93e-06 | 2 | 60 | 2 | 19051073 | |
| Pubmed | GJB2 and GJB6 gene mutations found in Indian probands with congenital hearing impairment. | 2.93e-06 | 2 | 60 | 2 | 20086291 | |
| Pubmed | Non-syndromic hearing impairment in a multi-ethnic population of Northeastern Brazil. | 2.93e-06 | 2 | 60 | 2 | 23684175 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 11668644 | ||
| Pubmed | Pediatric cholesteatoma and variants in the gene encoding connexin 26. | 2.93e-06 | 2 | 60 | 2 | 19877196 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 18294049 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 19173109 | ||
| Pubmed | Prevalence of GJB2 mutations and the del(GJB6-D13S1830) in Argentinean non-syndromic deaf patients. | 2.93e-06 | 2 | 60 | 2 | 15964725 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 19715470 | ||
| Pubmed | Connexins 26 and 30 are co-assembled to form gap junctions in the cochlea of mice. | 2.93e-06 | 2 | 60 | 2 | 12859965 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 12865758 | ||
| Pubmed | Genotyping for Cx26 and Cx30 mutations in cases with congenital hearing loss. | 2.93e-06 | 2 | 60 | 2 | 18554165 | |
| Pubmed | Connexin gene mutations among Ugandan patients with nonsyndromic sensorineural hearing loss. | 2.93e-06 | 2 | 60 | 2 | 24706568 | |
| Pubmed | GJB2 and GJB6 mutations in 165 Danish patients showing non-syndromic hearing impairment. | 2.93e-06 | 2 | 60 | 2 | 15345117 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 22292956 | ||
| Pubmed | Connexin 26 and 30 genes mutations in patients with chronic rhinosinusitis. | 2.93e-06 | 2 | 60 | 2 | 17989577 | |
| Pubmed | GJB2 and GJB6 screening in Tunisian patients with autosomal recessive deafness. | 2.93e-06 | 2 | 60 | 2 | 23434199 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 22704424 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 19465004 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 28779115 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 15464308 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 15464305 | ||
| Pubmed | Connexin 26 and connexin 30 mutations in children with nonsyndromic hearing loss. | 2.93e-06 | 2 | 60 | 2 | 15064611 | |
| Interaction | RGPD2 interactions | 1.52e-10 | 27 | 60 | 6 | int:RGPD2 | |
| Interaction | RGPD4 interactions | 5.00e-09 | 22 | 60 | 5 | int:RGPD4 | |
| Interaction | RGPD1 interactions | 6.82e-09 | 49 | 60 | 6 | int:RGPD1 | |
| Interaction | RGPD5 interactions | 1.40e-08 | 96 | 60 | 7 | int:RGPD5 | |
| Interaction | RGPD3 interactions | 2.75e-07 | 47 | 60 | 5 | int:RGPD3 | |
| Interaction | RGPD8 interactions | 2.72e-06 | 74 | 60 | 5 | int:RGPD8 | |
| Interaction | NPIPB6 interactions | 1.98e-05 | 18 | 60 | 3 | int:NPIPB6 | |
| Interaction | GJB6 interactions | 3.71e-05 | 22 | 60 | 3 | int:GJB6 | |
| Interaction | RANBP2 interactions | 9.54e-05 | 361 | 60 | 7 | int:RANBP2 | |
| Cytoband | 2q13 | 1.00e-04 | 68 | 60 | 3 | 2q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q12 | 2.56e-04 | 234 | 60 | 4 | chr13q12 | |
| Cytoband | 13q12.3 | 3.82e-04 | 22 | 60 | 2 | 13q12.3 | |
| Cytoband | 13q12 | 4.55e-04 | 24 | 60 | 2 | 13q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q12 | 5.22e-03 | 82 | 60 | 2 | chr2q12 | |
| Cytoband | 6q21 | 7.08e-03 | 96 | 60 | 2 | 6q21 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.86e-07 | 115 | 45 | 6 | 769 | |
| GeneFamily | Acyl-CoA thioesterases | 2.69e-04 | 10 | 45 | 2 | 41 | |
| GeneFamily | Solute carriers | 4.15e-04 | 395 | 45 | 6 | 752 | |
| GeneFamily | ATPase phospholipid transporting | 6.23e-04 | 15 | 45 | 2 | 1210 | |
| GeneFamily | Cadherin related | 8.04e-04 | 17 | 45 | 2 | 24 | |
| GeneFamily | Gap junction proteins | 1.36e-03 | 22 | 45 | 2 | 314 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 9.66e-07 | 33 | 60 | 4 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 2.86e-06 | 43 | 60 | 4 | MM3857 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.10e-07 | 248 | 59 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2 | 3.06e-06 | 145 | 59 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.04e-05 | 732 | 59 | 10 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ACSL6 FAT1 ABCA2 NR2E1 PAM SCRN1 CLSTN2 ADGRV1 SLC25A25 IQCK | 3.61e-05 | 747 | 59 | 10 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2 | 4.55e-05 | 71 | 59 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | 6.53e-05 | 496 | 59 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.04e-04 | 683 | 59 | 9 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2.Th, Lin-/lo CD25hi CD44+ cKit+, Thymus, avg-3 | 1.58e-04 | 420 | 59 | 7 | GSM791136_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.96e-04 | 743 | 59 | 9 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.32e-04 | 108 | 59 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.62e-04 | 205 | 59 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.93e-04 | 210 | 59 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.50e-04 | 339 | 59 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.93e-04 | 124 | 59 | 4 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500 | 3.99e-04 | 489 | 59 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.31e-04 | 127 | 59 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | 4.34e-04 | 496 | 59 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 4.45e-04 | 498 | 59 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 4.48e-04 | 658 | 59 | 8 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT2-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.38e-06 | 194 | 60 | 5 | 5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-06 | 196 | 60 | 5 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-Treg|ICU-SEP / Disease, Lineage and Cell Type | 4.39e-05 | 145 | 60 | 4 | ee99b58462f955b96d036aa67e343db047d66f64 | |
| ToppCell | COVID-19_Severe-CD8+_T_naive|COVID-19_Severe / disease group, cell group and cell class | 5.27e-05 | 152 | 60 | 4 | e6dbf20504c4fb73d1084b587e040855335b8959 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.41e-05 | 153 | 60 | 4 | 7480522a47e367f8facc4f5d599fbaf0b5ad4007 | |
| ToppCell | COVID-19_Severe-CD8+_T_naive|World / disease group, cell group and cell class | 5.54e-05 | 154 | 60 | 4 | b568417d88a78d8c46688847f0f5f4989bd36387 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.83e-05 | 156 | 60 | 4 | 53ded973358e3e48054130131e959f0d1f4ef60f | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.28e-05 | 159 | 60 | 4 | 1472536eea61d4f13033efe42f128bae1614fa74 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 160 | 60 | 4 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 166 | 60 | 4 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-SELL+_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.95e-05 | 169 | 60 | 4 | cc1b60eb50a274ffd72c67082c19e43af775e949 | |
| ToppCell | COVID-19_Severe-Treg|COVID-19_Severe / disease group, cell group and cell class | 8.13e-05 | 170 | 60 | 4 | d61269a51283125835884c4aa50623756c4fdda2 | |
| ToppCell | Control-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations) | 9.10e-05 | 175 | 60 | 4 | fb23858cfce71509cafbe0d9728e678012ff2962 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-05 | 175 | 60 | 4 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-NK_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.30e-05 | 176 | 60 | 4 | f0c01fc4f9c17c4d724642d9931731eef2b10258 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-05 | 177 | 60 | 4 | dba8b30a311051c22ca5f77697f5dbf9423c3ba0 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 1.01e-04 | 180 | 60 | 4 | 51a12fbad5fa7bb12e6d616a02ff9b5141e2b063 | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 1.04e-04 | 181 | 60 | 4 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 1.06e-04 | 182 | 60 | 4 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-04 | 182 | 60 | 4 | ed487f3a774812caa2903a646b60c86edcc1e65e | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 184 | 60 | 4 | 8fc047977fad38fcd26eebcc279a688efd342ed8 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 184 | 60 | 4 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | facs-Marrow-T-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 185 | 60 | 4 | e1fd0a807def8c2127194108b1a30c6de7024292 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class | 1.13e-04 | 185 | 60 | 4 | 846403edd4c8f646201d519055198fc38b7ffff9 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 185 | 60 | 4 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 185 | 60 | 4 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 186 | 60 | 4 | ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.17e-04 | 187 | 60 | 4 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-04 | 188 | 60 | 4 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Basophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 188 | 60 | 4 | 3638d85452de15a060146628fbbad9d2a36feb13 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 1.22e-04 | 189 | 60 | 4 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 189 | 60 | 4 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 191 | 60 | 4 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 60 | 4 | 468b5149d1533f03521844d3cce8633d44eb6ed4 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-T_reg|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-04 | 192 | 60 | 4 | 94e11f68767a899cbcc6984f9398877c1e464abc | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.33e-04 | 193 | 60 | 4 | 1cb666375bc4e1b11a146d20896c9b5ae6fd0887 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 194 | 60 | 4 | ba529c051f248d29f4222f4bc9801ba233859093 | |
| ToppCell | severe-Myeloid-CD16_Monocytes|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.38e-04 | 195 | 60 | 4 | 5badcfdeed2fb7453a9c144506ca91c5475cd35f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 195 | 60 | 4 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.41e-04 | 196 | 60 | 4 | 9a6e4eea19348a6e3379d3b872456ab6280cb74f | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.44e-04 | 197 | 60 | 4 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-04 | 197 | 60 | 4 | 749e0e332644543cbdf2ee38c2b301ce0a019a7f | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.44e-04 | 197 | 60 | 4 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 198 | 60 | 4 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-04 | 198 | 60 | 4 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-MAIT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-04 | 198 | 60 | 4 | f26150ae3fee6b2df2a51efaefbcfeb27f725a65 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-04 | 200 | 60 | 4 | 8872d5fa101d413fb43b4231d476878678543035 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-04 | 200 | 60 | 4 | 1779a8ff4443a85ac500f849764e86d9c7529b84 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-MAIT|Int-URO / Disease, condition lineage and cell class | 1.52e-04 | 200 | 60 | 4 | 043c18e79a969e37bbff86443e553ac09fe33f84 | |
| Disease | autosomal recessive nonsyndromic deafness 1A (implicated_via_orthology) | 3.41e-06 | 2 | 55 | 2 | DOID:0110475 (implicated_via_orthology) | |
| Disease | Keratitis-Ichthyosis-Deafness Syndrome | 3.41e-06 | 2 | 55 | 2 | C3665333 | |
| Disease | DFNA 3 Nonsyndromic Hearing Loss and Deafness | 3.41e-06 | 2 | 55 | 2 | cv:CN043589 | |
| Disease | Senter syndrome | 3.41e-06 | 2 | 55 | 2 | C0265336 | |
| Disease | autosomal recessive nonsyndromic deafness 1A (is_implicated_in) | 3.41e-06 | 2 | 55 | 2 | DOID:0110475 (is_implicated_in) | |
| Disease | Deafness, autosomal dominant nonsyndromic sensorineural 3 | 1.02e-05 | 3 | 55 | 2 | cv: | |
| Disease | Progressive hearing loss stapes fixation | 1.02e-05 | 3 | 55 | 2 | C1844678 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE 1A | 1.02e-05 | 3 | 55 | 2 | 220290 | |
| Disease | DEAFNESS, DIGENIC, GJB2/GJB6 (disorder) | 1.02e-05 | 3 | 55 | 2 | C2673760 | |
| Disease | DEAFNESS, DIGENIC, GJB2/GJB3 (disorder) | 1.02e-05 | 3 | 55 | 2 | C2673761 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE 1A (disorder) | 1.02e-05 | 3 | 55 | 2 | C2673759 | |
| Disease | X-linked mixed hearing loss with perilymphatic gusher | 1.02e-05 | 3 | 55 | 2 | cv:C1844678 | |
| Disease | DEAFNESS, X-LINKED 2 | 1.02e-05 | 3 | 55 | 2 | 304400 | |
| Disease | Autosomal recessive nonsyndromic hearing loss 1A | 1.02e-05 | 3 | 55 | 2 | cv:C2673759 | |
| Disease | Hidrotic Ectodermal Dysplasia | 3.40e-05 | 5 | 55 | 2 | C0162361 | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 1.52e-04 | 10 | 55 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | hearing impairment | 8.22e-04 | 98 | 55 | 3 | C1384666 | |
| Disease | response to methotrexate, drug-induced liver injury | 1.08e-03 | 26 | 55 | 2 | EFO_0004228, GO_0031427 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 1.34e-03 | 29 | 55 | 2 | cv:C5779548 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSFIPVERAESTFLF | 306 | Q86TX2 | |
| RFPKAEFAEVSKLVT | 246 | P02768 | |
| AFADVSVKFKAVPIT | 2146 | Q8WXG9 | |
| EKLVSVAFSTFVAKP | 101 | Q8WYK0 | |
| FRSPLSVFKRFKETT | 21 | P19021 | |
| FGFIFKSRTPETITI | 506 | Q8TF62 | |
| FVSRPTEKTVFTVFM | 181 | P29033 | |
| VTLFPDIKIVSTFAK | 656 | Q9H4D0 | |
| FKQPVFTVSKDSVLA | 871 | Q6W2J9 | |
| EFVSASFDKSIRIFP | 296 | Q9NV06 | |
| KKLGFVFTARTPFSV | 536 | Q9NTI2 | |
| PEKVVSAFLKVSSVF | 466 | P46060 | |
| FAAPLKSLVATFIVK | 781 | Q9NTI5 | |
| IKPVFDFLVNKFSTV | 226 | Q96DM1 | |
| PKFVFVSESVKRIFS | 1536 | Q99666 | |
| PKFVFVSESVKRIFS | 1536 | O14715 | |
| TVAKFITEFPLFLQT | 886 | Q4ADV7 | |
| FTEFFSIPFVEERLK | 186 | Q8N0W5 | |
| FIEPKTGVVSSKRFS | 1301 | Q14517 | |
| FPKSITVFFKEIEGI | 36 | P53985 | |
| LAETPKRAVKFFTFE | 81 | Q9BQT8 | |
| VIAKTPALRKFVFVF | 66 | Q9BZJ8 | |
| APRDVFIAVKTTKKF | 111 | Q8NES3 | |
| SVRPVEFEKVKVFLS | 51 | P21941 | |
| VPSSFSPFVEFKEKT | 441 | Q6P4R8 | |
| AFKVREFSVTDAVPF | 386 | Q92598 | |
| FTLFTFFKVPETKGK | 476 | P11168 | |
| TSVFVVDPKESFVKA | 36 | P12882 | |
| LRVIAEKKFFTVSPE | 66 | Q9Y5G1 | |
| SSFTEKVVYAFSPKI | 881 | A7KAX9 | |
| VKRIFSSEKSKPFAF | 1546 | A6NKT7 | |
| FISRPTEKTVFTIFM | 181 | O95452 | |
| VVEVFKPGKFVTTLF | 271 | P17707 | |
| IAAVQKVSPTFFFLR | 911 | Q92771 | |
| PASFVVFLVAEKSTK | 1806 | Q9BZC7 | |
| STPFHIFKVKVTTER | 216 | Q86X24 | |
| TFFRDFAISVVVKPS | 86 | P39059 | |
| EIFITFRVQKSPVFR | 326 | Q96EY1 | |
| FQKKVVASFPRTVLS | 26 | P51530 | |
| SSPFIIKVFDVVFET | 106 | Q52WX2 | |
| RSISPSTIEEVFFKK | 351 | Q9Y466 | |
| PKFVFGSESVKRIFS | 1521 | P0DJD0 | |
| KSFDAVVFDVLKVTP | 36 | Q86X27 | |
| TSPSNFKVRFFVLTK | 21 | Q08881 | |
| TLFIKNSISFPRFKV | 186 | P51575 | |
| VKRIFSSEKSKPFAF | 1546 | Q7Z3J3 | |
| ITIKDFLKTFSPDVF | 326 | Q9HA77 | |
| FLSKPVDVSKFGVIF | 181 | Q9Y617 | |
| SRSIFKPFIFVDDVK | 301 | Q12765 | |
| DFSGFLKVTEKVIFP | 296 | Q9UKU0 | |
| KSIFKLSVFIPSQEF | 31 | Q6KCM7 | |
| VTGFIPTKFLSDKVV | 1236 | Q7KZ85 | |
| KVPVSFEDVSVYFTK | 11 | A6NM28 | |
| EKFSPFADTFKKRVS | 741 | Q13905 | |
| FVSFPTQVLAKASKV | 206 | Q8TB61 | |
| FKTSRYFPTKVRSIV | 746 | Q6U841 | |
| VVFSLTTEEKVPFTF | 341 | Q8N0Z6 | |
| ILPGEIKTFTFFFKS | 491 | Q8TBZ2 | |
| TGLKVVSKRPEFFTF | 946 | Q9Y2L5 | |
| VEFTSVLKPVFAREK | 271 | Q5VTT5 |